Exemplar Studies Roundtable Discussion - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

Exemplar Studies Roundtable Discussion

Description:

Exemplar Studies Roundtable Discussion Charis Marwick Clinical Lead / Chair IIP User Group c.z.marwick_at_dundee.ac.uk charismarwick_at_nhs.net Outline Brief introduction ... – PowerPoint PPT presentation

Number of Views:178
Avg rating:3.0/5.0
Slides: 10
Provided by: Colin304
Category:

less

Transcript and Presenter's Notes

Title: Exemplar Studies Roundtable Discussion


1
Exemplar Studies Roundtable Discussion
  • Charis Marwick
  • Clinical Lead / Chair IIP User Group
  • c.z.marwick_at_dundee.ac.uk
  • charismarwick_at_nhs.net

2
Outline
  • Brief introduction to first sixteen studies
  • Four work streams
  • Describe two first phase studies
  • Clinical / research questions
  • Three studies for roundtable discussion
  • Aims of roundtable discussion
  • Concluding remarks

3
  • Risk factors work stream
  • Risk factors S. aureus and E. coli bacteraemia
    one-off study
  • Routine analysis risk factors for common
    bacteraemia
  • Technical work stream
  • Addition of local datasets e.g. ICNet, HEPMA, HMUD

4
Interventions work stream
  • Primary care prescribing and HA CDI
  • Primary care prescribing and other HAI
  • UTI primary care prescribing and AMR
  • Other primary care prescribing and AMR
  • High risk antibiotic prescribing and outcomes
    from emerging resistant pathogens

5
Outcomes work stream
  • Validation of IIP for SSI surveillance
  • Mortality associated with SSI, SAB, CDI, HAI
  • MRSA and CDI deaths routine reporting
  • 30 day mortality after blood culture
  • SAPG evaluation antibiotic policy
  • Standardised 30 day blood culture mortality
  • SPSP evaluation sepsis collaborative
  • Consequences of antibiotic policy changes
  • Intended and unintended (secondary care)
  • Surgical prophylaxis change
  • AKI in Lanarkshire then across Scotland

6
Risk factors S. aureus and E. coli bacteraemia
  • What risk markers are associated with adverse
    outcomes of S. aureus bacteraemia (MSSA or MRSA)
    or E. coli bacteraemia in Scotland?
  • What are the differences in risk markers between
  • Patients with these bacteraemia compared to
    hospitalised patients without bacteraemia?
  • Patients with MSSA compared to MRSA bacteraemia?
  • Patients with community onset bacteraemia
    compared to those with hospital onset?

7
UTI primary care prescribing and AMR
  1. What is the epidemiology of UTI prescribing?
  2. What proportion get subsequent different
    antimicrobials?
  3. What proportion are subsequently hospitalised and
    why?
  4. What are the differences in subsequent
    antimicrobial resistance by initial antibiotic
    prescribed?
  5. What factors are associated with antimicrobial
    resistance at patient, antibiotic use and
    practice levels?
  6. Is antimicrobial resistance and treatment failure
    associated with increased risk of hospital
    admission and death?

8
Studies for roundtable discussion
  • Impact of primary care antimicrobial prescribing
    (other than UTI) on antimicrobial resistance
  • Validation of IIP for surgical site infection
    surveillance
  • Intended and unintended consequences of changes
    in secondary care antibiotic policies

9
Aims of discussion
  • What do clinicians (you) want this study to do?
  • What questions should be answered?
  • What difference could the results make to patient
    care?
  • Please start with study assigned to your table
  • 30 minutes for discussion
Write a Comment
User Comments (0)
About PowerShow.com